Eli Lilly / Standard & Poor / Elan Corp / UnitedHealth Group Inc. / Merck / TSX VENTURE / E NT DiaMedica Inc. / President & CEO DiaMedica / Elite Pharmaceuticals Inc. / ANALYTICAL VALIDATION / /
Continent
Africa / Europe / /
Country
United States / /
Currency
USD / / /
Event
FDA Phase / /
IndustryTerm
stage biopharmaceutical / treatment of diabetes / DIABETIC KIDNEY DISEASE THERAPY / healthcare system / therapies for metabolic disorders / clinical stage product / diagnostic tool / /
IDF / American Diabetes Association / American Medical Association Juvenile Diabetes Research Foundation / Vanderbilt University / American Academy / European Union / /
Person
John Amatruda / D. Kim / Michael Giuffre / Richard D. Pilnik / Dawson J. Reimer / San Antonio Daniel Porte / Mark Williams / Matthew Charles / John Savage / DIABETIC KIDNEY / Rick Pauls / Paul Burn / /
Position
Disease DM199 President / VP / Franchise Head for Diabetes & Obesity / President / VP and Franchise Head / Leader for Insulin / Director / Product Develop’t / Director / IP & Business Develop’t Matthew Charles / DID YOU KNOW President / Consulting Chief Medical Officer / Vice President / Research 2011 1 Ted / Professor / Board Director / Director / The Sanford / Executive Vice President / Director / Texas Diabetes Institute / CFO / /